Suppr超能文献

再灌注时代高龄患者的临床特征及早期预后

Clinical characteristics and early outcomes of very elderly patients in the reperfusion era.

作者信息

Yagi Masahiro, Nakao Koichi, Honda Takashi, Tsurumi Yukio, Kasanuki Hiroshi

机构信息

The Cardiovascular Center, Saiseikai Kumamoto Hospital, 5-3-1 Chikami, Kumamoto 861-4193, Japan.

出版信息

Int J Cardiol. 2004 Mar;94(1):41-6. doi: 10.1016/j.ijcard.2003.03.019.

Abstract

BACKGROUND

Not much data is available regarding "real-world" clinical experience of very elderly patients with acute myocardial infarction (AMI) in the reperfusion era.

METHODS

We reviewed 483 patients (26%) between the ages of 75 and 85 from the 1855 patients with AMI. We analyzed 264 patients treated with reperfusion therapy (55%) and 219 patients treated with conservative therapy (45%) on their clinical characteristics and early outcomes.

RESULTS

Patients treated with reperfusion therapy were slightly younger (79.0 vs. 80.0 years, P=0.01), presented earlier (205 vs. 400 minutes, P<0.01) and had higher peak creatine kinase values (2634 vs. 1407 IU/l, P<0.01) than those treated with conservative therapy. Other clinical profiles including sex, prior myocardial infarction, hypertension, diabetes, and infarct location were similar to each other. There was a 92% success for reperfusion therapy. The incidence of recurrent ischemia, cardiac rupture, and cerebral hemorrhage was not significantly different between the two groups. In-hospital mortality in this study was 20.5%. In-hospital mortality was not significantly different between the two groups (19% vs. 23%, P=0.25). The multivariate analysis showed that age, infarct location, and Killip class were correlated to in-hospital mortality. The leading cause of in-hospital death was pump failure.

CONCLUSIONS

Older age and late presentation were correlated to conservative therapy in very elderly patients with AMI. Early outcomes were similar between the two treatment groups. In-hospital mortality seemed to be associated with impaired myocardial reserve.

摘要

背景

关于再灌注时代高龄急性心肌梗死(AMI)患者的“真实世界”临床经验,可用数据不多。

方法

我们从1855例AMI患者中回顾了483例年龄在75至85岁之间的患者(占26%)。我们分析了264例接受再灌注治疗的患者(占55%)和219例接受保守治疗的患者(占45%)的临床特征和早期结局。

结果

与接受保守治疗的患者相比,接受再灌注治疗的患者年龄稍小(79.0岁对80.0岁,P=0.01),就诊时间更早(205分钟对400分钟,P<0.01),肌酸激酶峰值更高(2634 IU/l对1407 IU/l,P<0.01)。其他临床特征,包括性别、既往心肌梗死、高血压、糖尿病和梗死部位,两组之间相似。再灌注治疗成功率为92%。两组之间复发性缺血、心脏破裂和脑出血的发生率无显著差异。本研究中的住院死亡率为20.5%。两组之间的住院死亡率无显著差异(19%对23%,P=0.25)。多因素分析显示,年龄、梗死部位和Killip分级与住院死亡率相关。住院死亡的主要原因是泵衰竭。

结论

高龄和就诊延迟与高龄AMI患者的保守治疗相关。两个治疗组的早期结局相似。住院死亡率似乎与心肌储备受损有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验